What's in store for analog semiconductor company, Texas Instruments in Q2?
kuriputosu


Texas Instruments (NASDAQ:TXN) is scheduled to announce Q2 earnings results on Tuesday, July 26th, after market close.
EPS Estimate is $2.15 (+8.0% Y/Y) and the consensus Revenue Estimate is $4.65B (+1.5% Y/Y).
Last quarter, beat both top and bottom line estimates, with backing from growth in industrial and automotive segment. Operating profit surged 32% Y/Y.


Analyst Ratings: UBS said that TXN could report Q2 revenue and earnings above Wall Street estimates, citing its proprietary Evidence Lab; the analyst at UBS expects TXN to generate $4.8B in revenue and $2.26 per share in earnings for the second-quarter, compared to Wall Street estimates of $4.65B and $2.13, respectively.
Citi cuts estimates citing deteriorating demand, he expects TXN to generate $17.8B in sales and EPS $7.57, down from $18.3B in revenue and EPS $7.79, "driven by the semi downturn.
TXN is trading at a discounted valuation and, with a 12-month upside of at least 13%, I consider the stock a buy.' The stock might be fairly valued at this point, but further stock price declines in the coming quarters seem likely. 'The valuation has come down, but when measured by P/E, P/FCF and historical average yield, the stock doesnât deserve a buy rating.'
Company has a quant rating of Hold with lowest factor grading to growth and highest to profitability.

Ratings of the stock against its peers:
Over the last 2 years, TXN has beaten EPS estimates 100% of the time and has beaten revenue estimates 100% of the time.
Over the last 3 months, EPS estimates have seen 1 upward revision and 10 downward. Revenue estimates have seen 0 upward revisions and 22 downward.
Related post: 'Semiconductor bill aims to shore up chip support inside of the U.S.'